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S U M M A R Y
The World Health Organization (WHO) Global Tuberculosis Report 2015 states that 28% of the world’s
9.6 million new tuberculosis (TB) cases are in the WHO Africa Region. The Mano River Union (MRU)
countries of West Africa–Guinea, Sierra Leone, and Liberia–have made incremental sustained
investments into TB control programmes over the past two decades. The devastating Ebola virus
disease (EVD) outbreak of 2014–2015 in West Africa impacted signiﬁcantly on all sectors of the
healthcare systems in theMRU countries, including the TB prevention and control programmes. The EVD
outbreak also had an adverse impact on the healthcare workforce and healthcare service delivery. At the
height of the EVD outbreak, numerous staff members in all MRU countries contracted EBV at the Ebola
treatment units and died. Many healthcare workers were also infected in healthcare facilities that were
not Ebola treatment units but were national hospitals and peripheral health units that were unprepared
for receiving patients with EVD. In all three MRU countries, the disruption to TB services due to the EVD
epidemic will no doubt have increased Mycobacterium tuberculosis transmission, TB morbidity and
mortality, and decreased patient adherence to TB treatment, and the likely impact will not be known for
several years to come [1_TD$DIFF]. In this viewpoint, the impact that the EVD outbreak had on TB diagnostic,
management, and prevention services is described. Vaccination against TB with BCG in children under
5 years of age was affected adversely by the EVD epidemic. The EVD outbreak was a result of global
failure and represents yet another ‘wake-up call’ to the international community, and particularly to
African governments, to reach a consensus on new ways of thinking at the national, regional, and global
levels for building healthcare systems that can sustain their function during outbreaks. This is necessary
so that other disease control programmes (like those for TB, malaria, and HIV) are not compromised
during the emergency measures of a severe epidemic.
Crown Copyright  2016 Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
The World Health Organization (WHO) Global Tuberculosis
Report 2015 states that 28% of the world’s 9.6 million new* Corresponding author.
E-mail address: rashidansumana@gmail.com (R. Ansumana).
http://dx.doi.org/10.1016/j.ijid.2016.10.010
1201-9712/Crown Copyright 2016 Published by Elsevier Ltd on behalf of International
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).tuberculosis (TB) cases are in the WHO Africa Region, where the
annual case detection rates are more than double the global
average of 133 per 100 000.1 [3_TD$DIFF] TB incidence has continued to fall by
an average of 1.5% per year since 2000 and is now 18% lower than
the level during the year 2000.1 Gains made by TB control
programmes need to be sustained, and an upward trajectory of
investments into activities of TB diagnostic, treatment, and
prevention services is required to bring TB under control.2 To thisSociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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and Liberia) and other West African countries have made
incremental and sustained investments into TB control pro-
grammes over the past two decades.1 However, the devastating
Ebola virus disease (EVD) outbreak of 2014–2015 in Guinea,
Liberia, and Sierra Leone,3–5 which claimed an estimated 11
310 lives and affected 28 616 people, impacted signiﬁcantly on all
sectors of the healthcare systems,4–14 including the TB prevention
and control programmes.4,6,9,11,13 In this viewpoint, the direct and
indirect impacts of the EVD outbreak on various aspects of TB
diagnostic, management, and prevention services are highlighted.
2. Lack of community education and public engagement
Media hype during any epidemic outbreak usually and
inadvertently creates stigma and fear-driven responses among
the affected communities. The EVD outbreakwas no different.15–17
Right from the onset, due tomisconstrued conspiracy theories that
were propagated by the local media and community gossip about
the perceived origin of Ebola virus (EBV), the EVD outbreak was
characterized by community fear, stigma, apprehension, and
misunderstanding of the role of healthcare centres operating
under prevailing epidemic conditions.15–17 Where these perceived
fears outweighed potential beneﬁts, the creation of Ebola
treatment centres further hindered healthcare-seeking behav-
iour.16,17 There was widespread reluctance of people with
symptoms such as fever to visit healthcare facilities for fear of
being diagnosed or suspected of having EVD. People also refrained
from visiting healthcare facilities to avoid being infected with EBV.
There was also heightened anxiety amongst some healthcare
workers (HCWs) to engage with or treat patients,18 and many
healthcare facilities in all three countries were closed during the
outbreak.
Several indicators of poor utilization of healthcare facilities and
services during the EVD outbreak have emerged. In Guinea, there
was a 50% decrease in outpatient visits and a 54% drop in hospital
admissions between August 2013 and August 2014.6 [4_TD$DIFF] In Liberia,
62% of health facilities were closed, and there was a 50% drop in
hospital deliveries and a 26% drop in child immunizations.6 [4_TD$DIFF] In Bong
County in Liberia, facility-based delivery decreased from over
500 per month to a low of 113 during the EVD outbreak.7 [5_TD$DIFF] In Sierra
Leone, only 4% of health facilities were closed, but there was a 39%
drop in children treated for malaria and a 23% decrease in facility-
based deliveries.7 Furthermore, there was an 18% decrease in
women accessing antenatal care, 22% decrease inwomen accessing
postnatal care, and 11%decrease in deliveries at healthcare centres,
with a concomitant 30% increase in maternal deaths and 24%
increase in newborn deaths.8
3. Impact of the EVD outbreak on TB services andmanagement
outcomes
The EVD outbreak impacted all sectors of the healthcare
systems, decreasing healthcare capacity in all three countries,
including the TB prevention and control programmes. Whilst EVD
caused an estimated 11 000 deaths in 2014 and 2015, TB claimed
about 11 900 lives in all three countries in the year 2014, with
Sierra Leone estimated to have had 3500, Liberia 3300, and Guinea
5100 TB-related deaths.1 Of the deaths from TB, about 2164 (95%
conﬁdence interval (CI) 1815–2548) in Sierra Leone, 3463 (95% CI
2808–4349) in Guinea, and 2164 (95% CI 1815–2548) in Liberia
were estimated to have been inﬂuenced by EVD.9
Moreover, the mortality rate for TB from 1990 to 2012 was
23 per 100 000 in Guinea, 143 per 100 000 in Sierra Leone, and
46 per 100 000 in Liberia.1 In 2014, which formed the learning
curve and peak of the EVD outbreak, the mortality rate in Guineadoubled to 43 per 100 000, and in Liberia it rose to 76 per 100
000 with Sierra Leone having 56 per 100 000. Some of these deaths
would have been preventable if routine TB care and prevention
efforts had been fully operational during the EVD outbreak.
The three MRU countries combined had over 400 DOTS centres
(directly observed treatment services), which ensured testing for
new and recurrent cases of TB, provided treatments, and
monitored adherence. In Kenema District, Eastern Sierra Leone,
for example, the DOTS centre at the Government Hospital in
Kenema did routine testing for TB, admitted TB patients for
treatment, and provided daily drugs for TB patients who had to
come to the hospital daily for their TB regimen, except for those
who were adherent. During the EVD outbreak, two HCWs at the
DOTS centre contracted EVD and died. Inpatients at the DOTS
centre discharged themselves, patients who were on regular
chemotherapy avoided the clinic, and prospective TB patients also
avoided the healthcare system. Even though the DOTS centre was
not closed, its functionality was impaired by the quarantine and
patient boycott. The patient boycott in Kenemawas related to how
Ebola was reported in the District.
In Liberia, DOTS centres were among the 62% of health facilities
that were closed during the EVD outbreak.7 DOTS centres are also
typically healthcare facilities that could be peripheral health units
or hospitals. While it was difﬁcult to close big hospitals completely
during the EVD outbreak, it was easier to close down peripheral
health units, some of which were DOTS centres in the MRU, and
this hampered TB diagnosis, treatment, and adherence.
In Guinea, in the forested region of Macenta, a 40% drop in
primary healthcare outpatient enrolment and a correlated 53%
decrease in TB diagnosis rate was reported in one study.10
However, in Conakry, Ortuno-Gutierrez and colleagues reported
a stable TB prevalence rate of 13% in both 2013 (when therewas no
documented EVD in Guinea) and 2014 (when therewas an ongoing
EVD outbreak in Guinea).11 The two datasets, one from a more
rural region with typically less access to healthcare and smaller
facilities and the other from a very urban setting, demonstrate that
the impact of EVD on the healthcare system was not symmetrical.
Facilities that were far from the capital cities experienced much
more reduced care during the outbreak.10,11
4. Effect of EVD on routine childhood BCG vaccination
The EVD epidemic disrupted healthcare services, including
routine childhood vaccination programmes.19 [6_TD$DIFF] TheWHOguidelines
for immunization programmes during the Ebola outbreak advised
against vaccination campaigns because of the threat of EBV
transmission.20[7_TD$DIFF] Vaccination against TB with BCG in children under
5 years of age was affected adversely by the EVD epidemic. Many
parents were gripped with fear, wary of the healthcare centres and
possibility of EBV transmission, and avoided vaccination clinics
and hospitals. Reasons for boycotting the clinics were varied and
included: (1) that children were weighed using the same scales
without these being disinfected in-between children, and (2)
HCWs had died after contracting EVD in the clinics and hospitals.
Others believed the conspiracy theories about EBV transmission
that ‘the injections received at hospitals contained EBV for killing
patients’ or that ‘when you visit the hospital, they will diagnose
you with Ebola’. As a consequence, over 3000 children missed
essential vaccinations for TB and other diseases such as measles,
which resulted in an outbreak of measles post-Ebola19 [6_TD$DIFF] and a rise in
new TB cases post-Ebola.
5. Effect of EVD on access to, and delivery of healthcare services
The EVD epidemic generated disruptive collateral damage to all
ongoing healthcare services.4–14 A large proportion of available
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ﬁght against EVD. This included manpower, vehicles, buildings,
and ﬁnancial resources. Even though the global funds for TB
increased by 2.3% (USD 13 million) in 2014, the amount available
to Liberia and Sierra Leone was low (although Guinea had
sustained TB funding). As a consequence, there was a failure to
bring in drugs that were adequate for TB control in some parts of
the MRU (Liberia and Sierra Leone) and this created the conditions
for the development of drug-resistant TB . In all three MRU
countries, the disruption to TB services due to the EVD epidemic
will no doubt have increased Mycobacterium tuberculosis trans-
mission (both drug-resistant and drug-sensitive strains), TB
morbidity and mortality, and patient adherence to TB treatment,
although the likely impact will not be known for several years to
come.
6. Effect of EVD on the healthcare workforce
The EVD outbreak adversely impacted all HCWs involved in
healthcare service delivery.8,18,21– [9_TD$DIFF]24 [8_TD$DIFF] At the height of the EVD
outbreak in all MRU countries, numerous staff members con-
tracted EBV at the Ebola treatment units and many died; these
included doctors, nurses, ambulance drivers, porters, and other
ancillary staff who received, examined, treated, nursed, and/or
moved patients with symptoms. Furthermore, many HCWs were
infected in healthcare facilities thatwere not Ebola treatment units
but were national hospitals and peripheral health units that were
unprepared for receiving patients with EVD. According to a WHO
report, there were 815 conﬁrmed and probable EVD cases among
theHCWs spanning January 2014 toMarch 2015,with 328 in Sierra
Leone, 288 in Liberia, and 199 in Guinea. Importantly, the deaths of
HCWs deprived the weak healthcare systems of much needed
human resources. For example in Sierra Leone, a nation of just over
seven million people, there are less than 1500 HCWs in the entire
country. Following the EVD epidemic, HCWs conveyed a feeling of
loss of trust within and across health facilities, and between HCWs
and communities.25 [10_TD$DIFF] Providers described feeling lonely, ostracized,
unloved, afraid, saddened, and no longer respected. They also
discussed restrictions on behaviours that enhance coping, includ-
ing attending burials and engaging in physical touch (hugging,
handshaking, sitting near, or eating with colleagues, patients, and
family members). Providers described infection prevention mea-
sures as necessary but divisive because screening booths and
protective equipment inhibited bonding or ‘suffering with’
patients. The EVD epidemic leaves a smaller workforce, which is
trying to deal with the ongoing TB epidemic, and this too will have
its toll on the TB care and control services in West Africa.
7. Lessons from the EVD epidemic
The EVD outbreak was a result of collective regional and
international failure to act swiftly and effectively,26,27 [11_TD$DIFF] and
provided yet another ‘wake-up call’ to the international commu-
nity, and particularly to African governments, for improving health
systems preparedness for infectious disease outbreaks.28 [12_TD$DIFF] It
illustrated the weaknesses and vulnerabilities of the current
healthcare infrastructure in African countries, the inability to
respond effectively to any new emerging or re-emerging infectious
disease with epidemic potential, and the actions required to
improve and preserve health services. The initial efforts to deal
with the EVD outbreaks were left to international charities and
non-governmental organizations (NGOs)27,29 [13_TD$DIFF] with extensive ex-
perience in dealing with famine, refugee, and humanitarian
emergencies, but not in dealing with public health and the clinical
management of major infectious disease outbreaks. The opportu-
nity to work together was not fully taken up by NGOs and themortality rate was high, most likely due to inexperience with
intravenous therapy,30[14_TD$DIFF] clinical management, and infection control
issues.31 [15_TD$DIFF]
Since the next epidemic cannot be predicted with any level of
certainty, TB and other health programmes will be under constant
threat.Will Zika virus return to Africa in epidemic form?32[16_TD$DIFF]Will the
Middle East respiratory syndrome coronavirus (MERS-CoV) evolve
and increase its human-to-human transmission rate potential and
spread across Africa and other continents?33 [17_TD$DIFF]Will the monkeypox
outbreak in the Democratic Republic of the Congo34 [18_TD$DIFF] suddenly re-
emerge as a threat, or will it be avian inﬂuenza?35 [19_TD$DIFF] This uncertainty
makes planning for future outbreaks very difﬁcult.
An important lesson from the EVD epidemic is that long-term
planning should be based on a holistic approach for strengthening
and building health systems and services, moving away from
disease-speciﬁc national programmes. Newways of thinking at the
national, regional, and global levels are required to strengthen
healthcare systems. This is required not only to improve the ability
of countries and regions to deal effectively with epidemic
infectious disease threats, but also to sustain functioning health
systems during outbreaks so that other disease control pro-
grammes (like those for TB,malaria, andHIV) are not compromised
during the emergency measures of a severe epidemic. This will
require skilled and trained staff at the national level, and such staff
are scarce in most low-income countries. It has previously been
argued that central or regional laboratories, able to perform rapid
advanced diagnostics on samples from patients with alarming
symptoms but without a clear diagnosis, are urgently needed for
early outbreak detection.32 [16_TD$DIFF]
8. The way forward?
There are important global leadership issues that need to be
considered. The role of the WHO in the EVD outbreak and its
capability to prevent and control epidemics in developing
countries has been criticized and questioned.36 [20_TD$DIFF] So who should
take the lead in the proactive surveillance, coordination, and
emergency response to future outbreaks? Apart from the WHO,
which has advisory and data surveillance functions but cannot act
as a funding agency, a suitable choice could be The Global Fund to
Fight AIDS, Tuberculosis andMalaria,37 [21_TD$DIFF]which provides substantial
funds for national programmes for all three diseases, especially in
Sub-Saharan Africa. The Global Fund is a public–private partner-
ship founded in 2001 and has invested over $10 billion in
interventions for HIV/AIDS, TB, and malaria in over 130 countries.
The Global Fund could work with national and regional authorities
to ensure cross-collaboration between the three diseases and close
alignment with the rest of the healthcare programme. The Global
Fund could also broaden its remit and support training, diagnostic,
and operational research activities for all three diseases. For TB
there are other funder initiatives that have arisen post-EVD that
provide opportunities for synergistic alignment of capacity
building and training across all African regions38[22_TD$DIFF] and for a ‘One
Health’ approach39 [23_TD$DIFF] to controlling emerging infections .
Conﬂict of interest: The authors declare no conﬂicts of interest.
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